Skip to main content

Table 1 Characteristics of the subjects in the two treatment groups.

From: Alternative vs. conventional treatment given on-demand for gastroesophageal reflux disease: a randomised controlled trial

Patients' characteristics

Eso20

PRA

Number of subjects

39

38

Male (no)

22 (56%)

21 (55%)

Age in years (mean)

47.8 (14.5)

46.2 (14.8)

BMI (mean)

26.2 (3.1)

25.7 (3.0)

Cups of coffee per day (mean)

3.0 (2.2)

3.3 (2.6)

Smokers (daily/past/never) (no)

9/12/18

10/16/12

Duration of reflux symptoms in years (mean)

8.0 (7.6)

8.0 (8.5)

Symptom score at inclusion (mean)

11.3 (3.9)

11.3 (4.1)

Degree of esophagitis (no)

  

- NERD

13 (33%)

15 (40%)

- Los Angeles Grade A

20 (51%)

17 (45%)

- Los Angeles Grade B

6 (15%)

6 (16%)

Hiatal hernia (no)

26 (67%)

24 (63%)

  1. The groups were well balanced. The results are given as number of patients (proportion in brackets) or mean (standard deviation in brackets).
  2. Eso20: Esomeprazole 20 mg.
  3. PRA: Pectin-based Raft-forming Agent.
  4. BMI: Body mass index.
  5. NERD: Non erosive reflux disease.